Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesTitan Medical Inc

Titan Medical Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.045 CAD -0.01 ( 10.00%)
Last update at 2024-10-15T17:23:00Z
VOLUME
117213
Market Cap
10.16M

Momentum Score

…

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.04
Low
0.05
High
52 Week Price Range
0.08
Low
1.30
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.05
Dividend Yield
-
Revenue TTM
17.13M
Revenue Per Share
0.15
Gross Profit TTM
20.09M
Debt / Equity
0.04
ROE
-24.95%
Net Debt
-30.98M
ROCE
2557.69%
Diluted EPS TTM
-0.43

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -42.60M -14.80M -24.18M -41.91M -22.64M
Net income -42.54M -14.86M -49.69M -22.14M -22.64M
Selling general administrative 10.90M 12.43M 7.49M 7.53M 6.57M
Selling and marketing expenses - - 0.14M 0.29M 0.23M
Gross profit - 20.09M 20.00M - 0.00M
Reconciled depreciation 0.86M 0.70M 0.24M 0.03M 0.03M
Ebit - -30.99M 2.95M -61.25M -22.64M
Ebitda -41.59M -29.61M 2.65M -61.21M -22.61M
Depreciation and amortization - 1.38M -0.30M 0.03M 0.03M
Operating income -47.09M -30.99M 2.95M -61.25M -39.69M
Other operating expenses - 51.08M 15.80M 59.27M 39.69M
Interest expense 0.15M 0.12M 1.09M 0.42M 0.98M
Tax provision -0.06M 0.06M - - -
Interest income 4.49M 15.58M 27.83M 19.92M 17.38M
Net interest income -0.00M -0.05M -2.88M -2.40M -1.02M
Income tax expense - 0.06M 25.50M -19.76M 0.00M
Total revenue 0.00M 20.09M 20.00M 0.00M 0.00M
Total operating expenses 44.77M 51.08M 15.80M 59.27M 39.69M
Cost of revenue - - - - 0.00M
Total other income expense net 2.18M 16.18M -27.13M 19.34M 17.05M
Net income from continuing ops -42.54M -14.86M -24.18M -41.91M -22.64M
Net income applicable to common shares -42.54M -14.86M -24.18M -41.91M -22.64M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 7.12M 47.22M 29.84M 3.38M 21.92M
Intangible assets 2.08M 1.92M 1.78M 1.60M 1.17M
Other current assets - 3.08M 0.77M 0.48M 9.13M
Total liab 10.28M 11.93M 43.65M 15.06M 17.70M
Total stockholder equity -3.16M 35.29M -13.81M -11.68M 4.22M
Other current liab 0.28M 10.55M 40.85M 15.03M 17.70M
Common stock 264.51M 263.36M 215.82M 194.86M 170.50M
Capital stock 264.51M 263.36M 215.82M 194.86M 170.50M
Retained earnings -284.68M -253.89M -239.03M -214.84M -172.94M
Other liab - 0.06M - - -
Cash 3.29M 32.31M 25.47M 0.81M 11.47M
Cash and equivalents - - 24.17M 0.67M -
Total current liabilities 8.96M 10.89M 42.90M 15.06M 17.70M
Net debt - -30.98M -22.67M -0.79M -11.47M
Short term debt 0.00M 0.35M 2.05M 0.02M 0.00M
Short long term debt - - 1.89M - -
Short long term debt total - 1.33M 2.80M 0.03M -
Other stockholder equity - 25.82M 9.40M 8.30M 7.17M
Property plant equipment 0.00M 1.64M 1.11M 0.03M 0.00M
Total current assets 5.04M 43.66M 26.95M 1.75M 20.74M
Net tangible assets - 33.37M -15.59M -13.28M 3.04M
Short term investments - - - - 11.37M
Net receivables 0.00M 8.28M 0.07M 0.08M 0.14M
Accounts payable - 5.62M 4.08M 10.85M 6.45M
Accumulated other comprehensive income - - -0.14M -0.00M -0.52M
Common stock total equity - - 215.82M 194.86M 170.50M
Non currrent assets other - - - 1.63M 1.17M
Non current assets total 2.08M 3.56M 2.89M 1.63M 1.17M
Capital lease obligations 1.71M 1.33M 0.92M 0.03M -
Long term debt total 1.32M 0.98M 0.75M 0.01M 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.02M -0.76M -0.60M -0.46M -0.42M
Change to liabilities - 1.09M -4.37M 4.97M 4.23M
Total cashflows from investing activities -1.02M -0.76M -0.60M -0.46M -0.42M
Net borrowings - 0.03M 1.41M -0.01M -0.01M
Total cash from financing activities -0.42M 44.21M 26.10M 35.76M 27.16M
Change to operating activities - -1.60M -0.00M 0.01M 0.01M
Net income -42.54M -14.86M -24.18M -41.91M -22.64M
Change in cash -29.02M 6.84M 24.65M -10.66M -14.66M
Begin period cash flow 32.31M 25.47M 0.81M 11.47M 26.13M
End period cash flow 3.29M 32.31M 25.47M 0.81M 11.47M
Total cash from operating activities -27.58M -36.62M -0.85M -45.96M -41.40M
Issuance of capital stock 0.00M 34.18M 24.69M 35.77M 27.16M
Depreciation 0.86M 0.70M 0.24M 0.03M 0.03M
Other cashflows from investing activities - - - - 0.00M
Change to account receivables - -10.03M -0.54M 8.34M -6.51M
Sale purchase of stock 0.00M 12.71M 24.69M 35.77M 27.16M
Other cashflows from financing activities - 10.31M 1.50M -0.46M -0.42M
Change to netincome - -11.92M 28.02M -17.39M -16.51M
Capital expenditures 1.02M 0.76M 0.60M 0.46M 0.42M
Change in working capital 12.19M -10.54M -4.92M 13.30M -2.28M
Stock based compensation 4.08M 4.04M 1.10M 1.65M 1.51M
Other non cash items 0.13M -16.01M 26.92M -19.04M -18.01M
Free cash flow -28.60M -37.37M -1.44M -46.42M -41.82M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TMD
Titan Medical Inc		 -0.01
10.00%		 0.04 - - 0.59 2.03 0.54 -0.31
PRN
Profound Medical Corp		 0.03
0.31%		 9.80 - - 21.06 3.72 11.94 -7.93

Profile*

Titan Medical Inc

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.

76 Berkeley Street, Toronto, ON, Canada, M5A 2W7

416 548 7522

https://www.titanmedicalinc.com

33

Name Title Year Born
Mr. Cary G. Vance CEO, Pres & Director 1966
Mr. Stephen L. Lemieux BA, CA, CPA, MMPA Chief Financial Officer NA
Mr. Jasminder Brar VP of Legal, IP & Strategic Initiatives, Corp. Sec. and Gen. Counsel NA
Ms. Kristen P. Galfetti VP of Investor Relations & Corp. Communications NA
Mr. Eric Heinz VP of Market & Corp. Devel. NA
Mr. Nate Jones Director of HR NA
Ms. Tammy Barnes Carrea VP of Quality and Regulatory Affairs NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…